Golden State Equity Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-54
Closed -$5.4K 673
2024
Q3
$5.4K Buy
+54
New +$5.4K ﹤0.01% 648